148 related articles for article (PubMed ID: 830399)
21. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
[TBL] [Abstract][Full Text] [Related]
22. Endogenous estrogens and risk of breast cancer by estrogen receptor status: a prospective study in postmenopausal women.
Zeleniuch-Jacquotte A; Toniolo P; Levitz M; Shore RE; Koenig KL; Banerjee S; Strax P; Pasternack BS
Cancer Epidemiol Biomarkers Prev; 1995 Dec; 4(8):857-60. PubMed ID: 8634657
[TBL] [Abstract][Full Text] [Related]
23. Estrogen receptors in hormone-dependent breast cancers.
Jensen EV
Cancer Res; 1975 Nov; 35(11 Pt. 2):3362-4. PubMed ID: 172222
[TBL] [Abstract][Full Text] [Related]
24. Antiestrogen treatment of breast cancer: an overview.
Pearson OH; Manni A; Arafah BM
Cancer Res; 1982 Aug; 42(8 Suppl):3424s-3429s. PubMed ID: 7044524
[TBL] [Abstract][Full Text] [Related]
25. Incidence of estrogen, progesterone and prolactin receptors in human breast cancer.
Calandra RS; Charreau EH; Royer de Giaroli M; Baldi A
Prog Clin Biol Res; 1984; 142():97-108. PubMed ID: 6709661
[TBL] [Abstract][Full Text] [Related]
26. Tumor-proliferative activity, progesterone receptor status, estrogen receptor level, and clinical outcome of estrogen receptor-positive advanced breast cancer.
Paradiso A; Tommasi S; Mangia A; Lorusso V; Simone G; De Lena M
Cancer Res; 1990 May; 50(10):2958-62. PubMed ID: 2334898
[TBL] [Abstract][Full Text] [Related]
27. [Present status of endocrine therapy of breast cancer: a surgeon's view].
Nomura Y
Gan To Kagaku Ryoho; 1984 May; 11(5):981-8. PubMed ID: 6426405
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemically determined estrogen receptor phenotype remains stable in recurrent and metastatic breast cancer.
Gomez-Fernandez C; Daneshbod Y; Nassiri M; Milikowski C; Alvarez C; Nadji M
Am J Clin Pathol; 2008 Dec; 130(6):879-82. PubMed ID: 19019763
[TBL] [Abstract][Full Text] [Related]
29. Predictive value of estrogen receptor status as assessed by ligand-binding assay in patients with early-stage breast cancer treated with breast conserving surgery and radiation therapy.
Takei H; Horiguchi J; Maemura M; Koibuchi Y; Oyama T; Yokoe T; Iino Y; Morishita Y
Oncol Rep; 2002; 9(2):375-8. PubMed ID: 11836611
[TBL] [Abstract][Full Text] [Related]
30. Stat5 expression predicts response to endocrine therapy and improves survival in estrogen receptor-positive breast cancer.
Yamashita H; Nishio M; Ando Y; Zhang Z; Hamaguchi M; Mita K; Kobayashi S; Fujii Y; Iwase H
Endocr Relat Cancer; 2006 Sep; 13(3):885-93. PubMed ID: 16954437
[TBL] [Abstract][Full Text] [Related]
31. Steroid hormone receptors in human breast cancer and clinical correlations.
Maass H; Engel B; Nowakowski H; Stolzenbach G; Trams G
Arch Geschwulstforsch; 1975; 45(5):423-9. PubMed ID: 174516
[TBL] [Abstract][Full Text] [Related]
32. An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer.
Henriksen KL; Rasmussen BB; Lykkesfeldt AE; Møller S; Ejlertsen B; Mouridsen HT
Acta Oncol; 2009; 48(4):522-31. PubMed ID: 19173092
[TBL] [Abstract][Full Text] [Related]
33. [Changing receptor status and treatment in breast cancer].
Nomura Y
Gan No Rinsho; 1983 May; 29(6):644-7. PubMed ID: 6876434
[TBL] [Abstract][Full Text] [Related]
34. Estrogen receptor in breast cancer of the Japanese.
Nomura Y
Gan; 1976 Oct; 67(5):703-11. PubMed ID: 190078
[TBL] [Abstract][Full Text] [Related]
35. Steroid receptors and response to endocrine ablations in women with metastatic cancer of the breast.
Dao TL; Nemoto T
Cancer; 1980 Dec; 46(12 Suppl):2779-82. PubMed ID: 7448720
[TBL] [Abstract][Full Text] [Related]
36. [Selection of patients with breast cancer with regard to endocrine therapy].
Cikes M; Pettavel J
Schweiz Med Wochenschr; 1977 Nov; 107(46):1645-55. PubMed ID: 199940
[TBL] [Abstract][Full Text] [Related]
37. Endocrine therapy in cancer.
Stoll BA
Practitioner; 1979 Feb; 222(1328):211-7. PubMed ID: 86186
[TBL] [Abstract][Full Text] [Related]
38. The surgical implications of estrophile protein estimations in carcinoma of the breast.
Walt AJ; Singhakowinta A; Brooks SC; Cortez A
Surgery; 1976 Oct; 80(4):506-12. PubMed ID: 184556
[TBL] [Abstract][Full Text] [Related]
39. Some comments on the necessity of receptor determination in human breast cancer.
Jonat W; Maass H
Cancer Res; 1978 Nov; 38(11 Pt 2):4305-6. PubMed ID: 698971
[TBL] [Abstract][Full Text] [Related]
40. Results and merit of estrogen receptor data derived from metastatic tumors of the breast.
Jochimsen PR; Ness SJ; Sherman BM
Surg Gynecol Obstet; 1978 Dec; 147(6):842-4. PubMed ID: 715657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
